The 10-second takeaway
For the quarter ended March 31 (Q1), Kindred Healthcare met expectations on revenue and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue greatly increased, while GAAP earnings per share shrank significantly.
Margins dropped across the board.
Kindred Healthcare logged revenue of $1.58 billion. The six analysts polled by S&P Capital IQ foresaw revenue of $1.6 billion on the same basis. GAAP-reported sales were 33% higher than the prior-year quarter's $1.19 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.40. The seven earnings estimates compiled by S&P Capital IQ predicted $0.38 per share. GAAP EPS of $0.35 for Q1 were 36% lower than the prior-year quarter's $0.55 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 33.1%, 240 basis points worse than the prior-year quarter. Operating margin was 3.5%, 20 basis points worse than the prior-year quarter. Net margin was 1.2%, 70 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $1.58 billion. On the bottom line, the average EPS estimate is $0.38.
Next year's average estimate for revenue is $6.3 billion. The average EPS estimate is $1.46.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 133 members rating the stock outperform and 11 members rating it underperform. Among 44 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 42 give Kindred Healthcare a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kindred Healthcare is outperform, with an average price target of $11.43.
If you're interested in health-care stocks like Kindred Healthcare, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add Kindred Healthcare to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.